Elismetrep Clinical Trials (2026): 3 Studies for Acute Migraine & Migraine
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
3 Elismetrep clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 2 indications (including Acute Migraine & Migraine) and 3,231 total planned enrollment. 2 Phase 3 Elismetrep trials and 1 Phase 2 are listed. 2 Elismetrep clinical trials are actively recruiting at 29 U.S. sites across 21 states. Most recent activity: NCT07674654 (Jun 2028).
Where to Participate: All Elismetrep Trial Sites in the U.S. (29 sites across 21 states)
Every actively recruiting Elismetreptrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| CA | The Neurology Group | Pomona91767 | NCT07645924 | Map |
| CO | IMMUNOe Research Centers | Centennial80112 | NCT07645924 | Map |
| GA | Sleep Care Research Institute d/b/a Clinical Research Atlanta-Stockbridge | Stockbridge30281 | NCT07645924 | Map |
| IL | Healthcare Research Network II, LLC | Flossmoor60477 | NCT07645924 | Map |
| KY | AMR Clinical - Lexington | Lexington40509 | NCT07645924 | Map |
| MD | Headlands Research - PharmaSite | Pikesville21208 | NCT07645924 | Map |
| MS | Proven Endpoints | Ridgeland39157 | NCT07645924 | Map |
| MO | StudyMetrix Research | City of Saint Peters63303 | NCT07645924 | Map |
| MO | Healthcare Research Network | Hazelwood63042 | NCT07645924 | Map |
| NV | Las Vegas Clinical Trials | North Las Vegas89030 | NCT07645924 | Map |
| NY | SPRI Clinical Trials, LLC | Brooklyn11235 | NCT07645924 | Map |
| NY | Upstate Clinical Research Associates | Williamsville14221 | NCT07645924 | Map |
| NC | Headache Wellness Center | Greensboro27405 | NCT07645924 | Map |
| OH | Hometown Research | Columbus43228 | NCT07645924 | Map |
| OH | CincyScience | West Chester45069 | NCT07645924 | Map |
| OK | DelRicht Research | Tulsa74133 | NCT07645924 | Map |
| OK | Tekton Research, Inc. | Yukon73099 | NCT07645924 | Map |
| PA | Lehigh Center for Clinical Research | Allentown18103 | NCT07645924 | Map |
| PA | Clinical Research Philadelphia | Philadelphia19114 | NCT07645924 | Map |
| SC | Coastal Carolina Research Center | North Charleston29405 | NCT07645924 | Map |
| TN | WR-ClinSearch, LLC | Chattanooga37421 | NCT07645924 | Map |
| TX | FutureSearch Trials of Neurology | Austin78731 | NCT07645924 | Map |
| TX | FutureSearch Trials of Dallas, LP | Dallas75251 | NCT07645924 | Map |
| TX | Clinpoint Trials | Waxahachie75165 | NCT07645924 | Map |
| UT | Pantheon Clinical Research | Bountiful84010 | NCT07645924 | Map |
| UT | J. Lewis Research, Inc. / Foothill Family Clinic | Salt Lake City84109 | NCT07645924 | Map |
| VA | Health Research of Hampton Roads, Inc. (HRHR) | Newport News23606 | NCT07645924 | Map |
| WV | Frontier Clinical Research | Morgantown26505 | NCT07645924 | Map |
| WI | Clinical Investigation Specialists, Inc. | Kenosha53144 | NCT07645924 | Map |
Elismetrep clinical trials at a glance: phase × recruitment status
| Phase | recruiting | completed | not yet recruiting | Total |
|---|---|---|---|---|
| P2 | 1 | 1 | ||
| P3 | 1 | 1 | 2 |
Recruiting Elismetrep clinical trials (2)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07674654 | K-304A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine | P3 | Acute Migraine | 1,000 | Jul 2026 |
| NCT07645924 | K-304A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine | P3 | Migraine | 1,800 | Jul 2026 |
Elismetrep clinical trials by indication
Acute Migraine (2)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT07674654 | K-304 | P3 | not yet recruiting | A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine |
| NCT06848075 | K-304 | P2 | completed | A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine |
Migraine (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT07645924 | K-304 | P3 | recruiting | A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine |
Elismetrep pivotal trial highlights (Phase 2/3/4)
Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.
| Acronym | NCT | Phase | Status | Indication | Enrollment | PubMed |
|---|---|---|---|---|---|---|
| K-304 | NCT07674654 | P3 | not yet recruiting | Acute Migraine | 1,000 | — |
| K-304 | NCT07645924 | P3 | recruiting | Migraine | 1,800 | — |
| K-304 | NCT06848075 | P2 | completed | Acute Migraine | 431 | — |
All Elismetrep trials (3)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07674654 | K-304 | A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine | P3 | not yet recruiting | 1,000 | Kallyope Inc. | Jul 2026 |
| NCT07645924 | K-304 | A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine | P3 | recruiting | 1,800 | Kallyope Inc. | Jul 2026 |
| NCT06848075 | K-304 | A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine | P2 | completed | 431 | Kallyope Inc. | Mar 2025 |
Elismetrep clinical trials: frequently asked questions
- How many Elismetrep clinical trials are there?
- 3 Elismetrep clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants. 1 is marked completed.
- Are Elismetrep clinical trials recruiting in 2026?
- Yes — 1 Elismetrep trial is actively recruiting in 2026, with 29 U.S. sites across 21 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is Elismetrep being studied for?
- Elismetrep is being studied for Acute Migraine, Migraine. The trials are grouped by indication on this page.
- What phase is Elismetrep in?
- Elismetrep clinical trials span 2 Phase 3, 1 Phase 2. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors Elismetrep clinical trials?
- The lead sponsor across the most Elismetrep trials is Kallyope Inc.. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Elismetrepas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: